Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$63.7M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$28.6M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$21.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$21.4M |
| 5 |
Conagra Brands
CAG
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$228M |
| 2 |
American International
AIG
|
+$18M |
| 3 |
EMC CORPORATION
EMC
|
+$14.6M |
| 4 |
General Dynamics
GD
|
+$14.4M |
| 5 |
PepsiCo
PEP
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.37% |
| 2 | Technology | 11.95% |
| 3 | Healthcare | 11.5% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NRF
901
DELISTED
NorthStar Realty Finance Corp.
NRF
| $192K | 0.01% |
14,600
-3,600
| -20% | -$46.5K |
2015 Q4
3 quarters
|
|
|
WDR
902
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $191K | 0.01% |
+10,537
| New | +$192K |
2016 Q3
0 quarters
|
|
903
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $190K | 0.01% |
+12,900
| New | +$214K |
2016 Q3
0 quarters
|
|
904
FNB Corp
FNB
$6.4B
| $186K | 0.01% |
15,146
+4,999
| +49% | +$61.7K |
2016 Q1
2 quarters
|
|
905
Ironwood Pharmaceuticals
IRWD
$775M
| $186K | 0.01% |
+13,970
| New | +$163K |
2016 Q3
0 quarters
|
|
906
DELISTED
Taylor Morrison
TMHC
| $185K | 0.01% |
10,500
-4,729
| -31% | -$79.8K |
2016 Q1
2 quarters
|
|
907
Kestrel Group
KG
$32.1M
| $184K | 0.01% |
+723
| New | +$193K |
2016 Q3
0 quarters
|
|
|
MEET
908
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $184K | 0.01% |
29,700
+1,700
| +6% | +$10.4K |
2016 Q2
1 quarter
|
|
909
DELISTED
Amicus Therapeutics
FOLD
| $181K | 0.01% |
+24,500
| New | +$165K |
2016 Q3
0 quarters
|
|
|
MDR
910
DELISTED
McDermott International
MDR
| $179K | 0.01% |
+11,933
| New | +$178K |
2016 Q3
0 quarters
|
|
911
PENN Entertainment
PENN
$2.49B
| $178K | 0.01% |
+13,100
| New | +$184K |
2016 Q3
0 quarters
|
|
|
SVU
912
DELISTED
SUPERVALU Inc.
SVU
| $176K | 0.01% |
5,035
-4,083
| -45% | -$144K |
2015 Q2
5 quarters
|
|
913
Summit Hotel Properties
INN
$778M
| $175K | 0.01% |
13,320
-4,922
| -27% | -$68.1K |
2016 Q2
1 quarter
|
|
914
Commercial Metals
CMC
$7.1B
| $172K | 0.01% |
+10,623
| New | +$173K |
2016 Q3
0 quarters
|
|
915
LSB Industries
LXU
$773M
| $172K | 0.01% |
26,013
-18,738
| -42% | -$159K |
2016 Q2
1 quarter
|
|
916
Independence Realty Trust
IRT
$3.55B
| $170K | 0.01% |
+18,900
| New | +$176K |
2016 Q3
0 quarters
|
|
917
Inovio Pharmaceuticals
INO
$166M
| $169K | 0.01% |
+1,508
| New | +$167K |
2016 Q3
0 quarters
|
|
918
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $166K | 0.01% |
+10,863
| New | +$439K |
2016 Q3
0 quarters
|
|
919
DELISTED
Dominion Diamond Corporation
DDC
| $163K | 0.01% |
+16,704
| New | +$150K |
2016 Q3
0 quarters
|
|
920
Adecoagro
AGRO
$1.32B
| $158K | 0.01% |
+13,822
| New | +$146K |
2016 Q3
0 quarters
|
|
|
KND
921
DELISTED
Kindred Healthcare
KND
| $158K | 0.01% |
15,502
+4,200
| +37% | +$46.6K |
2016 Q1
2 quarters
|
|
922
Tidewater
TDW
$3.54B
| $156K | 0.01% |
1,716
+410
| +31% | +$48.8K |
2015 Q4
3 quarters
|
|
|
SCLN
923
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $156K | 0.01% |
15,255
-2,800
| -16% | -$30.5K |
2016 Q2
1 quarter
|
|
924
CVR Energy
CVI
$4.34B
| $152K | 0.01% |
11,062
-5,438
| -33% | -$78.1K |
2016 Q2
1 quarter
|
|
925
DELISTED
Dynavax Technologies
DVAX
| $152K | 0.01% |
+14,451
| New | +$208K |
2016 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2016 Portfolio in Review
As of Q3 2016, Squarepoint held 1,524 positions worth $1.51B, down 6% from $1.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint withdrew a net $125M in Q3 2016, closing 544 positions and reducing 270 holdings. Its most notable exit was EMC CORPORATION, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Squarepoint opened a new position in State Street SPDR S&P 500 ETF Trust worth $63.7M.
- Squarepoint's largest Q3 2016 buy was State Street SPDR S&P 500 ETF Trust: 294,609 shares worth $63.7M.
- Squarepoint added most to Bristol-Myers Squibb in Q3 2016, an estimated $21.4M increase.
- Squarepoint's biggest Q3 2016 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $228M.
- Squarepoint fully exited EMC CORPORATION in Q3 2016, selling an estimated $14.6M.
- Squarepoint's ten largest holdings make up 15% of its $1.51B portfolio in Q3 2016.
- Squarepoint opened 456 new positions and closed 544 in Q3 2016.
- Squarepoint's portfolio value fell 6% quarter-over-quarter to $1.51B.
Based on Squarepoint's 13F filing for Q3 2016, filed 15 Nov 2016.